HESKA CORP.
HESKA CORP.
Open: -
Change: -
Volume: -
Low: -
High: -
High / Low range: -
Type: Stocks
Ticker: HSKA
ISIN:

Heska Corporation First Quarter 2020 Financial Results and Earnings Call Scheduled for May 7, 2020

  • 54
Heska Corporation First Quarter 2020 Financial Results and Earnings Call Scheduled for May 7, 2020

PR Newswire

LOVELAND, Colo., April 16, 2020 /PRNewswire/ -- Heska Corporation (NASDAQ: HSKA; "Heska" or the "Company"), a provider of advanced veterinary diagnostic and specialty products, plans to report its first quarter 2020 financial performance in a press release on Thursday, May 7, 2020 before the market opens, and to host a earnings call to discuss the results following the release at 9 a.m. MT / 11 a.m. ET.

To access the conference call:

From within the United States, please dial 1-866-548-4713
From outside of the United States, please dial 1-323-794-2093
Reference Conference ID: 3918137

The earnings call will be webcast live from the Company's website at: Heska Corporation First Quarter 2020 Earnings Call Webcast.

A telephonic replay will be available beginning at 2 p.m. ET Thursday, May 7 and will continue through 11:59 p.m. ET on Thursday, May 21, 2020. The webcast will be archived for 90 days.

To access the replay:

From within the United States, please dial 1-844-512-2921
From outside the United States, please dial 1-412-317-6671
Reference Replay Pin Number: 3918137

About Heska
Heska Corporation (NASDAQ: HSKA) manufactures, develops and sells advanced veterinary diagnostic and specialty healthcare products through its two business segments: Core Companion Animal Health ("CCA") and Other Vaccines and Pharmaceuticals ("OVP"). CCA segment includes Point of Care Laboratory testing instruments and consumables, primarily under a unique multi-year subscription model, digital imaging products, software and services, data services, allergy testing and immunotherapy, and single use offerings such as in-clinic diagnostic tests and heartworm preventive products. OVP segment includes private label vaccine and pharmaceutical production under third party agreements and channels, primarily for herd animal health.

                                                                                    

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/heska-corporation-first-quarter-2020-financial-results-and-earnings-call-scheduled-for-may-7-2020-301041692.html

SOURCE Heska Corporation

PR Newswire
PR Newswire

PR Newswire's news distribution, targeting, monitoring and marketing solutions help you connect and engage with target audiences across the globe.